Extracorporeal cardiac shock wave therapy ameliorates myocardial fibrosis by decreasing the amount of fibrocytes after acute myocardial infarction in pigs

Coronary Artery Disease

Volumn 24, Issue 6, 2013, Pages 509-515

  Lei, Pu Ping ^a   Tao, Si Ming ^a   Shuai, Qun ^b   Bao, Yu Xia ^a   Wang, Shang Wen ^a   Qu, Yong Qiang ^a   Wang, Dian Hua ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b Yunnan Police College   (China)

Author keywords

acute myocardial infarction; coronary artery disease; fibrocytes; myocardial fibrosis; shock wave

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COLLAGEN; STROMAL CELL DERIVED FACTOR 1;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY EMBOLISM; ARTICLE; CELL COUNT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY SPASM; DISEASE ASSOCIATION; DOMESTIC PIG; EXTRACORPOREAL LITHOTRIPSY; HEART MUSCLE FIBROSIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SHAM PROCEDURE; STAINING;

EID: 84881546166     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283640ec7     Document Type: Article

References (28)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113:e85-e151.
2. Mannheimer C, Camici P, Chester MR, Collins A, DeJongste M, Eliasson T, et al. The problem of chronic refractory angina: report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J 2002; 23:355-370.
3. Frangogiannis NG. The immune system and cardiac repair. Pharmacol Res 2008; 58:88-111.
4. Mias C, Lairez O, Trouche E, Roncalli J, Calise D, Seguelas MH, et al. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 2009; 27:2734-2743.
5. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, et al. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis 2007; 18:397-404.
6. Ito Y, Ito K, Shiroto T, Tsuburaya R, Yi GJ, Takeda M, et al. Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo. Coron Artery Dis 2010; 21:304-311.
7. Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci USA 2006; 103:18284-18289.
8. Lei PP, Qu YQ, Shuai Q, Tao SM, Bao YX, Wang Y, et al. Fibrocytes are associated with the fibrosis of coronary heart disease. Pathol Res Pract 2013; 209:36-43.
9. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004; 36:598-606.
10. Andersson-Sjoland A, De Alba CG, Nihlberg K, Becerril C, Ramirez R, Pardo A, et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008; 40:2129-2140.
11. Strieter RM, Gomperts BN, Keane MP. The role of CXC chemokines in pulmonary fibrosis. J Clin Invest 2007; 117:549-556.
12. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004; 110:3300-3305.
13. Chu PY, Mariani J, Finch S, McMullen JR, Sadoshima J, Marshall T, et al. Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol 2010; 176:1735-1742.
14. Kushner FG, Hand M, Smith SC Jr, King SB III, Anderson JL, Antman EM, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120:2271-2306.
15. Yasuda S, Shimokawa H. Acute myocardial infarction: the enduring challenge for cardiac protection and survival. Circ J 2009; 73:2000-2008.
16. Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, et al. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study. Circ J 2010; 74:93-100.
17. Seropian IM, Cerliani JP, Toldo S, Van Tassell BW, Ilarregui JM, Gonzalez GE, et al. Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. Am J Pathol 2013; 182:29-40.
18. Gu R, Zheng D, Bai J, Xie J, Dai Q, Xu B. Altered melusin pathways involved in cardiac remodeling following acute myocardial infarction. Cardiovasc Pathol 2012; 21:105-111.
19. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117:568-575.
20. Eghbali M, Weber KT. Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol Cell Biochem 1990; 96:1-14.
21. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 2007; 170:1807-1816.
22. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214:199-210.
23. Bucala R. Review series-inflammation & fibrosis. Fibrocytes and fibrosis. QJM 2012; 105:505-508.
24. Peng H, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Curr Opin Pharmacol 2012; 12:491-496.
25. Maharaj SS, Baroke E, Gauldie J, Kolb MR. Fibrocytes in chronic lung disease-facts and controversies. Pulm Pharmacol Ther 2012; 25:263-267.
26. Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol Rev 2000; 177:175-184.
27. Yang L, Scott PG, Dodd C, Medina A, Jiao H, Shankowsky HA, et al. Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 2005; 13:398-404.
28. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006; 114:2823-2830.